logo
A letter from Roche
The enrolment in the Phase III trial GENERATION HD1 study has been increased from 660 to 801 participants worldwide, as
Read more.
Update: RG6042 Phase III GENERATION HD1 study re-opens
Dear global patient community partners, Following your previous request to be kept up to date on the clinical development programme
Read more.
The inaugural conference of Huntington Disease Society of India
This picture was taken at the Inaugural conference of Huntington Disease Society of India. Among others, Svein Olaf Olsen –
Read more.
E-health for Huntington’s patients and families
What’s is Healthe-RND?  Huntington’s disease (HD) requires intensive cooperation between different medical disciplines and services, so-called ‘multidisciplinary care’.  Given the
Read more.